Optimax Technology Corporation manufactures and markets polarizers which are the key components used in manufacturing TFT-LCD (Thin Film Transistor Liquid Crystal Display) panels.

The Board Of Directors Of The Company Has
Approved The Investment In Jubilee International
Biomedical Co., Ltd.

Announcement Of The Record Date For The Cancellation
And Capital Reduction Of Shares Repurchased In The Third
Buyback, As Resolved By The Board Of Directors.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Optimax Technology (3051 TT)

The Board Of Directors Of The Company Has Approved The Investment In Jubilee International Biomedical Co., Ltd.

Announcement Of The Record Date For The Cancellation And Capital Reduction Of Shares Repurchased In The Third Buyback, As Resolved By The Board Of Directors.

The Company Is To Hold An Institutional Investor Conference On December 20, 2024.

The Company'S Consolidated Financial Report Of 2024q3 Approved By The Board Of Directors

Announcement That The Company Has Completed The Repurchase Of Treasury Shares

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)